The biopharmaceutical company operates six domestic locations and 16 overseas facilities, according to its website. PTC Therapeutics focuses on drugs and gene therapies for metabolism, neurology and oncology indications.
In October, PTC Therapeutics penned a partnership worth up to $1 billion.
